Literature DB >> 21763491

Identification of critical motifs within HIV-1 integrase required for importin α3 interaction and viral cDNA nuclear import.

Kallesh Danappa Jayappa1, Zhujun Ao, Ming Yang, Junzhi Wang, Xiaojian Yao.   

Abstract

The viral cDNA nuclear import is an important requirement for human immunodeficiency virus type 1 (HIV-1) replication in dividing and nondividing cells. Our recent study identified a specific interaction of importin α3 (Impα3) with HIV-1 integrase (IN) and its involvement in viral cDNA nuclear import. In this study, we have performed a more detailed investigation on the molecular mechanism of how HIV-1 IN interacts with Impα3. Our results revealed a reduced interaction between the two IN mutants INKK215,9AA (IN215,9) and INRK263,4AA (IN263,4) with Impα3, while an IN double mutant, IN215,9/263,4, was severely impaired for its Impα3-binding ability, even though it was still found interacting with other cofactors, IN interactor I and Transportin3. Immunostaining and fractionation analysis have shown that YFP-IN215,9/263,4 failed to localize in the nucleus of transfected cells. Also, we found that both major and minor nuclear localization signal binding grooves of Impα3 are involved in interaction with IN. All of these results suggest a cargo protein-import receptor type of interaction. Finally, the effect of IN215,9/263,4 mutations on HIV-1 replication was evaluated, and real-time quantitative PCR analysis showed that, while mutant virus (v215,9/263,4) had a slightly lowered total viral DNA, the 2-long-terminal-repeat DNA, a marker for nuclear import, was greatly reduced during v215,9/263,4 infection in both dividing and nondividing cells. Also, by cell fractionation assay, we found that a significant proportion of viral cDNA was still retained in cytoplasmic fraction of v215,9/263,4-infected cells. Overall, our study provides strong evidence that (211)KELQKQITK and (262)RRKAK regions of IN C-terminal domain are required for Impα3 interaction and HIV-1 cDNA nuclear import.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763491     DOI: 10.1016/j.jmb.2011.04.011

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  21 in total

1.  Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus.

Authors:  Xiang Li; Yasuhiro Koh; Alan Engelman
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  Interaction between Reverse Transcriptase and Integrase Is Required for Reverse Transcription during HIV-1 Replication.

Authors:  Shewit S Tekeste; Thomas A Wilkinson; Ethan M Weiner; Xiaowen Xu; Jennifer T Miller; Stuart F J Le Grice; Robert T Clubb; Samson A Chow
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

3.  The HIV-1 integrase mutant R263A/K264A is 2-fold defective for TRN-SR2 binding and viral nuclear import.

Authors:  Stéphanie De Houwer; Jonas Demeulemeester; Wannes Thys; Susana Rocha; Lieve Dirix; Rik Gijsbers; Frauke Christ; Zeger Debyser
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

4.  NKNK: a New Essential Motif in the C-Terminal Domain of HIV-1 Group M Integrases.

Authors:  Marine Kanja; Pierre Cappy; Nicolas Levy; Oyndamola Oladosu; Sylvie Schmidt; Paola Rossolillo; Flore Winter; Romain Gasser; Christiane Moog; Marc Ruff; Matteo Negroni; Daniela Lener
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 employs the cellular dynein light chain 1 protein for reverse transcription through interaction with its integrase protein.

Authors:  Kallesh Danappa Jayappa; Zhujun Ao; Xiaoxia Wang; Andrew J Mouland; Sudhanshu Shekhar; Xi Yang; Xiaojian Yao
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

Review 6.  Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition.

Authors:  Alan N Engelman
Journal:  J Biol Chem       Date:  2019-08-29       Impact factor: 5.157

7.  HIV Drug Resistance and the Advent of Integrase Inhibitors.

Authors:  Peter K Quashie; Thibault Mesplède; Mark A Wainberg
Journal:  Curr Infect Dis Rep       Date:  2013-02       Impact factor: 3.725

8.  Characterization of antiviral activity of benzamide derivative AH0109 against HIV-1 infection.

Authors:  Liyu Chen; Zhujun Ao; Kallesh Danappa Jayappa; Gary Kobinger; Shuiping Liu; Guojun Wu; Mark A Wainberg; Xiaojian Yao
Journal:  Antimicrob Agents Chemother       Date:  2013-05-13       Impact factor: 5.191

9.  Characterization of the R263K mutation in HIV-1 integrase that confers low-level resistance to the second-generation integrase strand transfer inhibitor dolutegravir.

Authors:  Peter K Quashie; Thibault Mesplède; Ying-Shan Han; Maureen Oliveira; Diane N Singhroy; Tamio Fujiwara; Mark R Underwood; Mark A Wainberg
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

10.  The HIV-1 passage from cytoplasm to nucleus: the process involving a complex exchange between the components of HIV-1 and cellular machinery to access nucleus and successful integration.

Authors:  Kallesh Danappa Jayappa; Zhujun Ao; Xiaojian Yao
Journal:  Int J Biochem Mol Biol       Date:  2012-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.